Off Patent December 2027
Tracleer
bosentan
Actelion Pharmaceuticals US Inc
Tablet, for suspension (oral) · NDA 209279
Last listed protection ends
December 28, 2027
The FDA lists 2 patents for Tracleer, and this is the day the last one ends. It is not the date a generic goes on sale.
Patents and exclusivities
- EndedPatent 8,309,126Claims the drug product
- Patent 7,959,945Claims the drug product